Ovarian 11β-hydroxysteroid dehydrogenase (11βHSD) activity is suppressed in women with anovulatory polycystic ovary syndrome (PCOS): Apparent role for ovarian androgens

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 8, 2013, Pages 3375-3383

  Michael, Anthony E ^a,b   Glenn, Christine ^c   Wood, Peter J ^c   Webb, Rachel J ^a   Pellatt, Laura ^a   Mason, Helen D ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYANDROSTENEDIONE; 11BETA HYDROXYSTEROID DEHYDROGENASE; 7BETA HYDROXYPRASTERONE; ANDROGEN; ANDROSTENEDIONE; HYDROCORTISONE; INSULIN; METFORMIN; PRASTERONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; ANDROGEN BLOOD LEVEL; ANOVULATION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; FEMALE INFERTILITY; GRANULOSA LUTEIN CELL; HORMONE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROCORTISONE METABOLISM; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLITE; OVARY CELL; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE; OXIDATION; PRIORITY JOURNAL;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ADULT; ANDROGENS; ANOVULATION; CORTISONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDROCORTISONE; INFERTILITY, FEMALE; INSULIN; METFORMIN; MIDDLE AGED; OVARY; POLYCYSTIC OVARY SYNDROME;

EID: 84881527867     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1385     Document Type: Article

References (40)

1. Franks S, Mason H, Willis D. Follicular dynamics in the polycystic ovary syndrome. Mol Cell Endocrinol. 2000;163:49-52.
2. Polson DW, Wadsworth J, Adams J, Franks S. Polycystic ovaries: a common finding in normal women. Lancet. 1988;1:870-872.
3. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Hum Reprod. 2004;19:41-47.
4. Seckl JR, Walker BR. 11β-Hydroxysteroid dehydrogenase type 1: a tissue-specific amplifier of glucocorticoid action. Endocrinology. 2001;142:1371-1376.
5. Draper N, Stewart PM. 11β-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. J Endocrinol. 2005;186:251-271.
6. Draper N, Walker EA, Bujalska IJ, et al. Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet. 2003;34:434-439.
7. Atanasov AG, Nashev LG, Schweizer RA, Frick C, Odermatt A. Hexose-6-phosphate dehydrogenase determines the reaction direction of 11β-hydroxysteroid dehydrogenases type 1 as an oxoreductase. FEBS Lett. 2004;571:129-133.
8. Zhang YL, Zhong X, Gjoka Z, et al. H6PDH interacts directly with 11β-HSD1: implications for determining the directionality of glucocorticoid catalysis. Arch Biochem Biophys. 2009;483:45-54.
9. Michael AE, Gregory L, Piercy EC, Walker SM, Shaw RW, Cooke BA. Ovarian 11β-hydroxysteroid dehydrogenase activity is inversely related to the outcome of in vitro fertilization-embryo transfer treatment cycles. Fertil Steril. 1995;64:590-598.
10. Michael AE, Collins TD, Norgate DP, Gregory L, Wood PJ, Cooke BA. Relationship between ovarian cortisol:cortisone ratios and the clinical outcome of in vitro fertilization and embryo transfer (IVFET). Clin Endocrinol (Oxf). 1999;51:535-540.
11. Thurston LM, Norgate DP, Jonas KC, et al. Ovarian modulators of type 1 11β-hydroxysteroid dehydrogenase (11βHSD) activity and intra-follicular cortisol:cortisone ratios correlate with the clinical outcome of IVF. Hum Reprod. 2003;18:1603-1612.
12. Sunak N, Green DF, Abeydeera LR, Thurston LM, Michael AE. Implication of cortisol and 11β-hydroxysteroid dehydrogenase (11βHSD) enzymes in the development of porcine (Sus scrofa domestica) ovarian follicles and cysts. Reproduction. 2007;133:1149-1158.
13. Thurston LM, Abayasekara DR, Michael AE. 11β-Hydroxysteroid dehydrogenase expression and activities in bovine granulosa cells and corpora lutea implicate corticosteroids in bovine ovarian physiology. J Endocrinol. 2007;193:299-310.
14. Stewart PM, Shackleton CH, Beastall GH, Edwards CR. 5'-Reductase activity in polycystic ovary syndrome. Lancet. 1990;335:431-433.
15. Rodin A, Thakkar H, Taylor N, Clayton R. Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11β-hydroxysteroid dehydrogenase. N Engl J Med. 1994;330:460-465.
16. Tsilchorozidou T, Honour JW, Conway GS. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5'-reduction but not the elevated adrenal steroid production rates. J Clin Endocrinol Metab. 2003;88:5907-5913.
17. Jamieson A, Wallace AM, Andrew R, et al. Apparent cortisone reductase deficiency: a functional defect in 11β-hydroxysteroid dehydrogenase type 1. J Clin Endocrinol Metab. 1999;84:3570-3574.
18. Biason-Lauber A, Suter SL, Shackleton CH, Zachmann M. Apparent cortisone reductase deficiency: a rare cause of hyperandrogenemia and hypercortisolism. Horm Res. 2000;53:260-266.
19. Gambineri A, Vicennati V, Genghini S, et al. Genetic variation in 11β-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism amongst lean women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:2295-2302.
20. Draper N, Powell BL, Franks S, Conway GS, Stewart PM, McCarthy MI. Variants implicated in cortisone reductase deficiency do not contribute to susceptibility to common forms of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2006;65:64-70.
21. Qin K, Rosenfield RL. Mutations of the hexose-6-phosphate dehydrogenase gene rarely cause hyperandrogenic polycystic ovarian syndrome. Steroids. 2011;76:135-139.
22. Chua AK, Azziz R, Goodarzi MO. Association study of CYP17 and HSD11B1 in polycystic ovary syndrome utilizing comprehensive gene coverage. Mol Hum Reprod. 2012;18:320-324.
23. Michael AE, Evagelatou M, Norgate DP, et al. Isoforms of 11β-hydroxysteroid dehydrogenase in human granulosa-lutein cells. Mol Cell Endocrinol. 1997;132:43-52.
24. Tetsuka M, Thomas FJ, Thomas MJ, Anderson RA, Mason JI, Hillier SG. Differential expression of messenger ribonucleic acids encoding 11β-hydroxysteroid dehydrogenase types 1 and 2 in human granulosa cells. J Clin Endocrinol Metab. 1997;82:2006-2009.
25. Thurston LM, Chin E, Jonas KC, et al. Expression of 11β- hydroxysteroid dehydrogenase (11βHSD) proteins in luteinizing human granulosa cells. J Endocrinol. 2003;178:127-135.
26. Tetsuka M, Milne M, Simpson GE, Hillier SG. Expression of 11β-hydroxysteroid dehydrogenase, glucocorticoid receptor, and mineralocorticoid receptor genes in rat ovary. Biol Reprod. 1999;60: 330-335.
27. Yong PY, Thong KJ, Andrew R, Walker BR, Hillier SG. Development-related increase in cortisol biosynthesis by human granulosa cells. J Clin Endocrinol Metab. 2000;85:4728-4733.
28. Moore JS, Monson JP, Kaltsas G, et al. Modulation of 11β- hydroxysteroid dehydrogenase isozymes by growth hormone and insulinlike growth factor: in vivo and in vitro studies. J Clin Endocrinol Metab. 1999;84:4172-4177.
29. Owen EJ, Holownia P, Conway GS, Jacobs HS, Honour JW. 11β-hydroxyandrostenedione in plasma, follicular fluid and granulosa cells of women with normal and polycystic ovaries. Fertil Steril. 1992;58:713-718.
30. Mason HD, Willis DS, Beard RW, Winston RM, Margara R, Franks S. Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotrophins and sex steroids in follicular fluid. J Clin Endocrinol Metab. 1994;79:1355-1360.
31. Moore A, Aitken R, Burke C, et al. Cortisol assay: guidelines for the provision of a clinical biochemistry service. Ann Clin Biochem. 1985;22:435-454.
32. Wood PJ, Glenn C, Donovan SJ. A simple RIA for serum cortisone without preliminary steroid extraction. J Endocrinol. 1996;148 (Suppl):319 (Abstract)
33. Richardson MC, Ingamells S, Simonis CD, et al. Stimulation of lactate production in human granulosa cells by metformin and potential involvement of adenosine 5' monophosphate-activated protein kinase. J Clin Endocrinol Metab. 2009;94:670-677.
34. Willis D, Mason H, Gilling-Smith C, Franks S. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab. 1996;81:302-309.
35. Rice S, Christoforidis N, Gadd C, et al. Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries. Hum Reprod. 2005;20:373-381.
36. Robinzon B, Michael KK, Ripp SL, Winters SJ, Prough RA. Glucocorticoids inhibit interconversion of 7-hydroxy and 7-oxo metabolites of dehydroepiandrosterone: a role for 11β-hydroxysteroid dehydrogenases? Arch Biochem Biophys. 2003;412:251-258.
37. Hult M, Elleby B, Shafqat N, et al. Human and rodent type 1 11β-hydroxysteroid dehydrogenases are 7β-hydroxycholesterol dehydrogenases involved in oxysterol metabolism. Cell Mol Life Sci. 2004;61:992-999.
38. Schweizer RA, Zürcher M, Balazs Z, Dick B, Odermatt A. Rapid hepatic metabolism of 7-ketocholesterol by 11β-hydroxysteroid dehydrogenase type 1: species-specific differences between the rat, human, and hamster enzyme. J Biol Chem. 2004;279:18415-18424.
39. Gu S, Ripp SL, Prough RA, Geoghegan TE. Dehydroepiandrosterone affects the expression of multiple genes in rat liver including 11β-hydroxysteroid dehydrogenase type 1: a cDNA array analysis. Mol Pharmacol. 2003;63:722-731.
40. Apostolova G, Schweizer RA, Balazs Z, Kostadinova RM, Odermatt A. Dehydroepiandrosterone inhibits the amplification of glucorticoid action in adipose tissue. Am J Physiol Endocrinol Metab. 2005;288:E957-E964.